Displaying 1 - 9 of 9
  • Print
Preparations (1) Prescribing in Renal Disease Prescribing in Liver Disease
Active Ingredient LINAGLIPTIN
Therapeutic Class DIPEPTIDYL PEPTIDASE INHIBITORS
Indications
Caution
Dose Range
Drug Interactions
Pregnancy
Breast Feeding
Preparations (5) Prescribing in Renal Disease Prescribing in Liver Disease
Active Ingredient METFORMIN XR | SITAGLIPTIN
Therapeutic Class DIPEPTIDYL PEPTIDASE INHIBITORS
Indications
Caution
Dose Range
Drug Interactions
Pregnancy
Breast Feeding
Preparations (4) Prescribing in Renal Disease Prescribing in Liver Disease
Active Ingredient METFORMIN | SAXAGLIPTIN
Therapeutic Class DIPEPTIDYL PEPTIDASE INHIBITORS
Indications
Caution
Dose Range
Drug Interactions
Pregnancy
Breast Feeding
Preparations (5) Prescribing in Renal Disease Prescribing in Liver Disease
Active Ingredient METFORMIN | SITAGLIPTIN
Therapeutic Class DIPEPTIDYL PEPTIDASE INHIBITORS
Indications
Caution
Dose Range
Drug Interactions
Pregnancy
Breast Feeding
Preparations (3) Prescribing in Renal Disease Prescribing in Liver Disease
Active Ingredient METFORMIN | VILDAGLIPTIN
Therapeutic Class DIPEPTIDYL PEPTIDASE INHIBITORS
Indications
Caution
Dose Range
Drug Interactions
Pregnancy
Breast Feeding
Preparations (6) Prescribing in Renal Disease Prescribing in Liver Disease
Active Ingredient SITAGLIPTIN
Therapeutic Class DIPEPTIDYL PEPTIDASE INHIBITORS
Indications
Caution
Dose Range
Drug Interactions
Pregnancy
Breast Feeding
Preparations Prescribing in Renal Disease Prescribing in Liver Disease
Active Ingredient SITAGLIPTIN | METFORMIN
Therapeutic Class DIPEPTIDYL PEPTIDASE INHIBITORS
Indications
Caution
Dose Range
Drug Interactions
Pregnancy
Breast Feeding
Preparations (1) Prescribing in Renal Disease Prescribing in Liver Disease
Active Ingredient VILDAGLIPTIN
Therapeutic Class DIPEPTIDYL PEPTIDASE INHIBITORS
Indications
Caution
Dose Range
Drug Interactions
Pregnancy
Breast Feeding
Preparations Prescribing in Renal Disease Prescribing in Liver Disease
Active Ingredient VILDAGLIPTIN | METFORMIN
Therapeutic Class DIPEPTIDYL PEPTIDASE INHIBITORS
Indications Type 2 diabetes mellitus as monotherapy (if metformin inappropriate), or in combination with other antidiabetic drugs (including insulin) if existing treatment fails to achieve adequate glycaemic cont More ...
Caution Asthenia, dizziness, headache, nausea;, peripheral oedema, tremor.
Dose Range 1 tablet twice daily based on patient’s current metformin dose.
Drug Interactions
Pregnancy
Breast Feeding